advertisement
Friedman DS 53
Showing records 1 to 25 | Display all abstracts from Friedman DS96490 Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease: The Zhongshan Angle Closure Prevention Trial
Xu BY
Ophthalmology 2022; 129: 267-275
95667 Lessons Learned From 2 Large Community-based Glaucoma Screening Studies
Kolomeyer NN
Journal of Glaucoma 2021; 30: 875-877
96438 Longitudinal changes in daily patterns of objectively measured physical activity after falls in older adults with varying degrees of glaucoma
E JY
EClinicalMedicine 2021; 40: 101097
95997 The Singapore Asymptomatic Narrow Angles Laser Iridotomy Study: Five-Year Results of a Randomized Controlled Trial
Baskaran M
Ophthalmology 2022; 129: 147-158
96054 Racial and Socioeconomic Differences in Eye Care Utilization among Medicare Beneficiaries with Glaucoma
Halawa OA
Ophthalmology 2022; 129: 397-405
95667 Lessons Learned From 2 Large Community-based Glaucoma Screening Studies
Kolomeyer NN
Journal of Glaucoma 2021; 30: 875-877
95750 Anatomic Changes and Predictors of Angle Widening after Laser Peripheral Iridotomy: The Zhongshan Angle Closure Prevention Trial
Xu BY
Ophthalmology 2021; 128: 1161-1168
95667 Lessons Learned From 2 Large Community-based Glaucoma Screening Studies
Katz LJ
Journal of Glaucoma 2021; 30: 875-877
96054 Racial and Socioeconomic Differences in Eye Care Utilization among Medicare Beneficiaries with Glaucoma
Kolli A
Ophthalmology 2022; 129: 397-405
95750 Anatomic Changes and Predictors of Angle Widening after Laser Peripheral Iridotomy: The Zhongshan Angle Closure Prevention Trial
Friedman DS
Ophthalmology 2021; 128: 1161-1168
96490 Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease: The Zhongshan Angle Closure Prevention Trial
Friedman DS
Ophthalmology 2022; 129: 267-275
95997 The Singapore Asymptomatic Narrow Angles Laser Iridotomy Study: Five-Year Results of a Randomized Controlled Trial
Kumar RS
Ophthalmology 2022; 129: 147-158
96438 Longitudinal changes in daily patterns of objectively measured physical activity after falls in older adults with varying degrees of glaucoma
Mihailovic A
EClinicalMedicine 2021; 40: 101097
96490 Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease: The Zhongshan Angle Closure Prevention Trial
Foster PJ
Ophthalmology 2022; 129: 267-275
96438 Longitudinal changes in daily patterns of objectively measured physical activity after falls in older adults with varying degrees of glaucoma
Schrack JA
EClinicalMedicine 2021; 40: 101097
95667 Lessons Learned From 2 Large Community-based Glaucoma Screening Studies
Hark LA
Journal of Glaucoma 2021; 30: 875-877
96438 Longitudinal changes in daily patterns of objectively measured physical activity after falls in older adults with varying degrees of glaucoma
Schrack JA
EClinicalMedicine 2021; 40: 101097
95750 Anatomic Changes and Predictors of Angle Widening after Laser Peripheral Iridotomy: The Zhongshan Angle Closure Prevention Trial
Foster PJ
Ophthalmology 2021; 128: 1161-1168
96054 Racial and Socioeconomic Differences in Eye Care Utilization among Medicare Beneficiaries with Glaucoma
Oh G
Ophthalmology 2022; 129: 397-405
95997 The Singapore Asymptomatic Narrow Angles Laser Iridotomy Study: Five-Year Results of a Randomized Controlled Trial
Friedman DS
Ophthalmology 2022; 129: 147-158
96490 Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease: The Zhongshan Angle Closure Prevention Trial
Jiang Y
Ophthalmology 2022; 129: 267-275
96054 Racial and Socioeconomic Differences in Eye Care Utilization among Medicare Beneficiaries with Glaucoma
Mitchell WG
Ophthalmology 2022; 129: 397-405
95667 Lessons Learned From 2 Large Community-based Glaucoma Screening Studies
Wahl M
Journal of Glaucoma 2021; 30: 875-877
96438 Longitudinal changes in daily patterns of objectively measured physical activity after falls in older adults with varying degrees of glaucoma
Garzon C
EClinicalMedicine 2021; 40: 101097
95997 The Singapore Asymptomatic Narrow Angles Laser Iridotomy Study: Five-Year Results of a Randomized Controlled Trial
Lu QS
Ophthalmology 2022; 129: 147-158
